# Myocardial Injury in Remifentanil-based Versus Sevoflurane-sufentanil Balanced Regimens in OPCAB Surgery

> **NCT02499445** · NA · COMPLETED · sponsor: **Konkuk University Medical Center** · enrollment: 120 (actual)

## Conditions studied

- Ischemic Heart Disease

## Interventions

- **DRUG:** Remifentanil
- **DRUG:** sevoflurane 1
- **DRUG:** sevoflurane 2
- **DRUG:** propofol
- **DRUG:** sufentanil

## Key facts

- **NCT ID:** NCT02499445
- **Lead sponsor:** Konkuk University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2014-10
- **Final completion:** 2014-11
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2015-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02499445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02499445, "Myocardial Injury in Remifentanil-based Versus Sevoflurane-sufentanil Balanced Regimens in OPCAB Surgery". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02499445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*